Equities research analysts expect Exponent, Inc. (NASDAQ:EXPO) to report $78.45 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Exponent’s earnings, with the lowest sales estimate coming in at $77.80 million and the highest estimate coming in at $79.10 million. Exponent posted sales of $72.75 million during the same quarter last year, which suggests a positive year over year growth rate of 7.8%. The business is expected to report its next earnings report after the market closes on Thursday, February 1st.

On average, analysts expect that Exponent will report full-year sales of $78.45 million for the current fiscal year, with estimates ranging from $324.75 million to $326.10 million. For the next year, analysts forecast that the firm will report sales of $335.96 million per share, with estimates ranging from $331.41 million to $340.50 million. Zacks’ sales calculations are a mean average based on a survey of research analysts that cover Exponent.

Exponent (NASDAQ:EXPO) last issued its earnings results on Wednesday, October 18th. The business services provider reported $0.54 EPS for the quarter, topping the consensus estimate of $0.45 by $0.09. The company had revenue of $87.60 million for the quarter, compared to analyst estimates of $79.69 million. Exponent had a net margin of 16.46% and a return on equity of 17.21%. The business’s revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.42 EPS.

Several brokerages have commented on EXPO. Zacks Investment Research lowered shares of Exponent from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, December 19th. SunTrust Banks reaffirmed a “hold” rating and set a $77.00 price target on shares of Exponent in a research note on Thursday, October 19th. BidaskClub downgraded Exponent from a “hold” rating to a “sell” rating in a research note on Friday, December 15th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and set a $82.00 price target on shares of Exponent in a research note on Sunday, November 5th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. Exponent presently has an average rating of “Hold” and an average target price of $80.00.

Several hedge funds and other institutional investors have recently bought and sold shares of EXPO. Schwab Charles Investment Management Inc. increased its stake in shares of Exponent by 11.0% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 116,210 shares of the business services provider’s stock valued at $6,776,000 after acquiring an additional 11,488 shares during the last quarter. Legal & General Group Plc increased its stake in shares of Exponent by 9.3% during the 2nd quarter. Legal & General Group Plc now owns 50,587 shares of the business services provider’s stock valued at $2,948,000 after acquiring an additional 4,318 shares during the last quarter. Victory Capital Management Inc. increased its stake in shares of Exponent by 17.7% during the 2nd quarter. Victory Capital Management Inc. now owns 3,157 shares of the business services provider’s stock valued at $184,000 after acquiring an additional 474 shares during the last quarter. Principal Financial Group Inc. increased its stake in shares of Exponent by 2.3% during the 2nd quarter. Principal Financial Group Inc. now owns 210,098 shares of the business services provider’s stock valued at $12,249,000 after acquiring an additional 4,794 shares during the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. acquired a new position in shares of Exponent during the 2nd quarter valued at about $432,000. 88.61% of the stock is owned by institutional investors.

Shares of Exponent (NASDAQ:EXPO) opened at $71.80 on Tuesday. The company has a market cap of $1,853.21, a price-to-earnings ratio of 35.02 and a beta of 0.57. Exponent has a 1 year low of $55.75 and a 1 year high of $77.15.

The company also recently announced a quarterly dividend, which was paid on Friday, December 22nd. Investors of record on Friday, December 1st were paid a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 1.17%. The ex-dividend date was Thursday, November 30th. Exponent’s payout ratio is 40.98%.

COPYRIGHT VIOLATION WARNING: This news story was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://www.americanbankingnews.com/2018/01/16/zacks-brokerages-anticipate-exponent-inc-expo-will-post-quarterly-sales-of-78-45-million.html.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.